1. Standard operating procedure combined with comprehensive quality control system for multiple LC-MS platforms urinary proteomics.
- Author
-
Liu, Xiang, Sun, Haidan, Hou, Xinhang, Sun, Jiameng, Tang, Min, Zhang, Yong-Biao, Zhang, Yongqian, Sun, Wei, Liu, Chao, Gao, Youhe, Tang, Shuxuan, Shen, Ziyun, Liu, Kehui, Jia, Lulu, Wei, Jing, Wu, Jianqiang, Tang, Xiaoyue, Li, Yanchang, Wang, Guibin, and Sui, Xinying
- Subjects
ANALYTICAL chemistry ,PROTEOMICS ,STANDARD operating procedure ,INDIVIDUALIZED medicine ,QUALITY control - Abstract
Urinary proteomics is emerging as a potent tool for detecting sensitive and non-invasive biomarkers. At present, the comparability of urinary proteomics data across diverse liquid chromatography−mass spectrometry (LC-MS) platforms remains an area that requires investigation. In this study, we conduct a comprehensive evaluation of urinary proteome across multiple LC-MS platforms. To systematically analyze and assess the quality of large-scale urinary proteomics data, we develop a comprehensive quality control (QC) system named MSCohort, which extracted 81 metrics for individual experiment and the whole cohort quality evaluation. Additionally, we present a standard operating procedure (SOP) for high-throughput urinary proteome analysis based on MSCohort QC system. Our study involves 20 LC-MS platforms and reveals that, when combined with a comprehensive QC system and a unified SOP, the data generated by data-independent acquisition (DIA) workflow in urine QC samples exhibit high robustness, sensitivity, and reproducibility across multiple LC-MS platforms. Furthermore, we apply this SOP to hybrid benchmarking samples and clinical colorectal cancer (CRC) urinary proteome including 527 experiments. Across three different LC-MS platforms, the analyses report high quantitative reproducibility and consistent disease patterns. This work lays the groundwork for large-scale clinical urinary proteomics studies spanning multiple platforms, paving the way for precision medicine research. Urinary proteomics offers sensitive, non-invasive biomarkers, but cross-platform LC-MS data comparability requires investigation. Here, the authors evaluate 20 LC-MS platforms, developing MSCohort, a QC system with 81 metrics, and a unified SOP, paving the way for precision medicine research. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF